BioLineRx Annouces Positive Results for Phase 3 GENESIS Trial in Stem-Cell Mobilization
Shots:
- Results of Ph 3 GENESIS trial comparing combination of BL-8040 plus G-CSF vs. G-CSF in multiple myeloma patients
- GENESIS is an open-label- single-arm study with 30 patients. First 11 patients showed safety and tolerability
- Results: In trial 9/11 (82%) showed ≥6x106CD34 cells/kg after 2 apheresis; 7/11 (64%)- showed ≥6x106 CD34 cells/kg post 1 session- which lead to reduction in treatment cost and better QoL
Ref: Biolinerx | Image: LinkedIn
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com